We are live on
!
Find out more
TD Asset Management Portfolio holdings
AUM
$123B
1-Year Est. Return
34.51%
This Fund
S&P 500
This Quarter
Est. Return
+11%
1 Year Est. Return
+34.51%
3 Year Est. Return
+98.94%
5 Year Est. Return
+122.3%
10 Year Est. Return
+375.56%
AUM
$107B
AUM Growth
+$5.79B
(+5.7%)
Cap. Flow
-$2.7B
Cap. Flow
% of AUM
-2.51%
Top 10 Holdings %
Top 10 Hldgs %
24.55%
Holding
1,462
New
74
Increased
672
Reduced
527
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$365M |
| 2 |
Procter & Gamble
PG
|
+$299M |
| 3 |
Meta Platforms (Facebook)
META
|
+$268M |
| 4 |
Republic Services
RSG
|
+$247M |
| 5 |
CRH
CRH
|
+$244M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.38B |
| 2 |
Apple
AAPL
|
+$827M |
| 3 |
UnitedHealth
UNH
|
+$478M |
| 4 |
Microsoft
MSFT
|
+$428M |
| 5 |
NVIDIA
NVDA
|
+$347M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.15% |
| 2 | Financials | 19.67% |
| 3 | Healthcare | 11.58% |
| 4 | Industrials | 10.73% |
| 5 | Consumer Discretionary | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Hyatt Hotels
H
$16.2B
| $563K | ﹤0.01% |
3,530
-200
| -5% | -$28.2K |
|
1277
AdvanSix
ASIX
$541M
| $563K | ﹤0.01% |
19,700
-8,800
| -31% | -$235K |
|
1278
Nuvation Bio
NUVB
$2.19B
| $561K | ﹤0.01% |
+154,200
| New | +$296K |
|
1279
Helios Technologies
HLIO
$2.62B
| $559K | ﹤0.01% |
12,506
-23,264
| -65% | -$999K |
|
1280
Kearny Financial
KRNY
$614M
| $555K | ﹤0.01% |
86,212
| – | – |
|
|
CGC
1281
Canopy Growth
CGC
$402M
| $555K | ﹤0.01% |
64,382
+12,658
| +24% | +$54.6K |
|
|
AZPN
1282
DELISTED
Aspen Technology Inc
AZPN
| $551K | ﹤0.01% |
2,582
-219
| -8% | -$43.2K |
|
1283
ALX Oncology
ALXO
$266M
| $546K | ﹤0.01% |
49,000
-21,400
| -30% | -$301K |
|
1284
Murphy USA
MUSA
$11B
| $545K | ﹤0.01% |
+1,300
| New | +$508K |
|
|
NOA
1285
North American Construction
NOA
$368M
| $537K | ﹤0.01% |
24,117
+500
| +2% | +$11.6K |
|
1286
Otter Tail
OTTR
$3.81B
| $536K | ﹤0.01% |
+6,200
| New | +$539K |
|
1287
BILL Holdings
BILL
$4.67B
| $528K | ﹤0.01% |
7,682
-61,868
| -89% | -$4.32M |
|
1288
Dropbox
DBX
$7.75B
| $526K | ﹤0.01% |
21,634
| – | – |
|
1289
Westlake Corp
WLK
$8.9B
| $524K | ﹤0.01% |
3,428
-100
| -3% | -$14.1K |
|
|
PRFT
1290
DELISTED
Perficient Inc
PRFT
| $523K | ﹤0.01% |
9,300
| – | – |
|
1291
Tower Semiconductor
TSEM
$26.2B
| $514K | ﹤0.01% |
15,650
+7,531
| +93% | +$234K |
|
1292
AnaptysBio
ANAB
$1.57B
| $509K | ﹤0.01% |
22,600
-8,800
| -28% | -$208K |
|
1293
Liberty Global Class C
LBTYK
$3.57B
| $509K | ﹤0.01% |
28,845
+7,573
| +36% | +$146K |
|
1294
Taysha Gene Therapies
TSHA
$1.65B
| $504K | ﹤0.01% |
175,600
| – | – |
|
1295
Transcat
TRNS
$831M
| $501K | ﹤0.01% |
4,494
| – | – |
|
1296
Gossamer Bio
GOSS
$81.9M
| $498K | ﹤0.01% |
422,260
-82,540
| -16% | -$90.9K |
|
1297
UroGen Pharma
URGN
$1.87B
| $492K | ﹤0.01% |
+32,800
| New | +$536K |
|
1298
Orchestra BioMed
OBIO
$246M
| $488K | ﹤0.01% |
92,678
| – | – |
|
|
MREO
1299
Mereo BioPharma
MREO
$52.8M
| $488K | ﹤0.01% |
+148,000
| New | +$501K |
|
1300
ePlus
PLUS
$2.46B
| $487K | ﹤0.01% |
6,200
-500
| -7% | -$38.9K |
|
Similar funds
VAM
TD Asset Management's Q1 2024 Portfolio in Review
As of Q1 2024, TD Asset Management held 1,462 positions worth $107B, up 5.7% from $102B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
TD Asset Management's Q1 2024 filing shows 74 new, 672 increased, 527 reduced and 81 closed positions. Its largest new stake was Middleby: 121,279 shares worth $19.5M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.38B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- TD Asset Management's largest Q1 2024 buy was Middleby: 121,279 shares worth $19.5M.
- TD Asset Management added most to AbbVie in Q1 2024, an estimated $365M increase.
- TD Asset Management's biggest Q1 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.38B.
- TD Asset Management fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $59.9M.
- TD Asset Management's ten largest holdings make up 25% of its $107B portfolio in Q1 2024.
- TD Asset Management opened 74 new positions and closed 81 in Q1 2024.
- TD Asset Management's portfolio value rose 5.7% quarter-over-quarter to $107B.
Based on TD Asset Management's 13F filing for Q1 2024, filed 8 May 2024.